Tamoxifen, a very popular adjuvant treatment for breast cancer may be recommended for chemoprevention. However, it frequently causes unscheduled uterine bleeding, which could be due to its estrogenic effect on uterine tissue causing proliferation or even cancer. An intra-uterine device releasing progestagen is found to prevent this effect of tamoxifen on uterine tissue.
Go to Previous Page
Go to Next Page